Search clinical trials for: NSC-102816
Total 422 results
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Celgene CorporationCompletedAzacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)Leukemia | Stem Cell TransplantationUnited States
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemiaUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; Celgene CorporationCompleted
-
M.D. Anderson Cancer CenterNovartis Pharmaceuticals; Celgene CorporationCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterTerminatedLeukemiaUnited States
-
M.D. Anderson Cancer CenterKura Oncology, Inc.Not yet recruitingRefractory Acute Leukemia | Pediatric RelapsedUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingHodgkin's LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
M.D. Anderson Cancer CenterYukiguni Maitake Company Ltd.Terminated
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Allife Medical Science and Technology Co., Ltd.Beijing Hospital; The First People's Hospital of Yunnan Province/First People... and other collaboratorsUnknown
-
M.D. Anderson Cancer CenterHiberCell, Inc.Not yet recruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; CelgeneActive, not recruitingMetastatic Melanoma | Melanoma and Other Malignant Neoplasms of SkinUnited States
-
M.D. Anderson Cancer CenterSeagen Inc.Terminated
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminatedLeukemiaUnited States
-
M.D. Anderson Cancer CenterBayerCompleted
-
M.D. Anderson Cancer CenterCTI BioPharmaTerminated
-
M.D. Anderson Cancer CenterAriad PharmaceuticalsWithdrawnLeukemia | FLT3-Mutated Acute Myeloid Leukemia | FLT3-Mutated High-Risk Myelodysplastic Syndrome
-
M.D. Anderson Cancer CenterBayer; Celgene; Onyx Therapeutics, Inc.Completed
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedSolid TumorsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Glioblastoma | Recurrent Malignant Glioma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | Recurrent Gliosarcoma | Recurrent Anaplastic Astrocytoma | Recurrent Anaplastic Oligoastrocytoma | Recurrent Anaplastic OligodendrogliomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLeukemia | Myelodysplastic Syndrome | Recurrent Myelodysplastic SyndromeUnited States
-
SanofiGynecologic Oncology GroupCompleted
-
Fundación Pública Andaluza para la Investigación...Completed
-
University of Alabama at BirminghamRecruitingGlioblastoma Multiforme | Gliosarcoma | Anaplastic AstrocytomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Pfizer; Oncovir, Inc.Completed
-
University of OklahomaNational Cancer Institute (NCI)Recruiting
-
Hadassah Medical OrganizationNexcella, IncRecruiting
-
Northwestern UniversityNot yet recruitingGlioma, Malignant | New Diagnosis Tumor
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedAdenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells MaturedMelanoma (Skin)United States
-
Dana-Farber Cancer InstituteCompleted
-
TetraLogic PharmaceuticalsCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumors | Central Nervous System TumorsUnited States, Canada, Australia, Switzerland, Netherlands, New Zealand
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); MedarexCompletedMelanoma (Skin)United States
-
Recursion Pharmaceuticals Inc.RecruitingNeurofibromatosis Type 2United States
-
TriStar HealthWithdrawn
-
Legacy Health SystemDevers Eye Institute; Lions Eye Bank of Oregon Vision Research Laboratory; Fischer...UnknownFuchs' Corneal Endothelial DystrophyUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastoma | Brain Tumors | Central Nervous System TumorsUnited States, Australia, Canada
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Active, not recruitingRecurrent Glioblastoma Multiforme | Progressive Glioblastoma Multiforme | Anaplastic Astrocytoma or GliosarcomaUnited States
-
National Science Council, TaiwanUnknownEsophageal Variceal Rebleeding
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedGallbladder Cancer | Extrahepatic Bile Duct CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); MedarexCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI); Pediatric Oncology GroupCompletedBrain Tumors | Central Nervous System TumorsUnited States, Puerto Rico, Switzerland, Australia, Canada